Stem Cell Research In Cardiology - A Report By Research And Markets

Main Category: Stem Cell Research
Article Date: 20 Nov 2008 - 2:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

This report specifies the importance of Stem Cell Research in Cardiology. The study is segmented by Source (Allogenic and Autogenic) and by Type (Bone Marrow Stem Cells, Embryonic Stem Cells, and Other). Projections and estimates are graphically illustrated by geographic region encompassing North America, Europe, Asia-Pacific, and Rest of World. Business profiles of 23 major companies are discussed in the report. The report serves as a guide to global market for Stem Cell Research in Cardiology covering 229 companies that are engaged in stem cell R&D, storage, banking, discovery, testing and supply of products and services. Major Contract Research Organizations and Universities serving the industry are also covered in the Corporate Directory section of this report. Information related to recent product releases, product developments, partnerships, collaborations, mergers and acquisitions, ethical issues, regulatory affairs, and other areas of concern is also covered in the report. Exhibits (27) complement the text.

Heart disease has assumed great magnitude as an endemic health problem. Cardiology field has seen significant efforts in clinical research in the past few years with the development of new drugs and surgical modalities of therapy as well. However, the mortality rates remain very high. In this context, stem cell applications in cardiology assume great significance since stem cells have been found to be successfully used in tissue regeneration. Heart disease, including myocardial infarction and ischemia, can be treated with the applications of stem cells.

The concept of stem cell transplantation to regenerate the myocardium and better the working of the heart has received a great deal of attention in recent times. Small-scale studies in the pre-clinical and clinical stages support the use of stem cells in treating heart disease. However similar such studies must be carried out on a larger-scale to corroborate the findings and prove stem cell therapy as a viable alternative method of treating patients with heart disease.

The global market for Stem Cells in Cardiology is projected to reach about US$ 3.5 billion by 2012. Adult stem cells market is the largest tapped market while cord blood and embryonic stem cell markets, though with huge market potential, are still in infancy stages. Embryonic stem cells to treat cardiac disorders is a very interesting area of research. However, due to various ethical issues, this area is mired in debates all over the world.

Countries Covered:
-North America
-Europe
-Asia-Pacific
-Rest of World

-- Table of Contents
-- Companies Mentioned

About Research and Markets

We are the leading source for international market research and market data. We hold '000's of major research publications from most of the leading publishers, consultants and analysts. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research & Markets